Table 2.

Overview of breakthrough cases and administered vaccines per vaccine type.

	Comirnaty/Spikevax	Vaxzevria	Jcovden
N (breakthrough cases)	243	60	72
N (administered vaccines in week 26)	178,267	6,762	15,652
% breakthrough per vaccinea	0.14%	0.89%	0.46%

^aThe percentage of breakthrough cases per vaccine was calculated by dividing the total number of breakthrough cases recorded until the end of week 28 by the total number of administered vaccines in week 26, to ensure only vaccines received ≥14 days were included.